BARCELONA—A radiotherapy dose of more than 54 Gy improved survival in children with localized cerebral ependymoma in a large multicenter study from France that looked at the role of age, grade and dose on outcome in 177 patients over a period of 13 years. Oncology Times reporter Sarah Maxwell discussed the findings—presented at the 3rd ESTRO Forum—with lead study author Anne Ducassou MD, from Institut Claudius Regaud in Toulouse, France.
You may also like...
Two-step immunotherapy brings promise in advanced ovarian cancer 8 Apr, 2013 ASCO Audio Journal of Oncology in Advance – June 1st, 2007 – reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles 2 Jun, 2007 Enzalutamide in metastatic castration resistant prostate cancer: over 75s benefit too 24 Mar, 2013 Disease-free survival doubles for patients treated with immunoconjugate TDM-1 for their HER-2 positive metastatic breast cancers 19 Nov, 2013
- Previous story Boosting Radiotherapy Dose Improved Survival in Children with Ependymoma
- Next story ‘Rescanning’ Optimizes Pencil Beam Proton Delivery to Moving Lung Tumor
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014